NCT00192218

Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program

A Phase IV Study to Evaluate the Effectiveness of Flumist (Influenza Vaccine, Live Intranasal) Vaccination in a School-Based Intervention Program

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 3,022 (actual)
• Sponsor: MedImmune LLC · Industry
• Sex: All
• Age: 5 Years – 17 Years
• Healthy volunteers: Accepted

Summary

To measure the effectiveness of influenza vaccination in school children by comparing, between target(i.e., children are offered FluMist) and control (i.e., children are not offered FluMist) school families.

Conditions

• Influenza

Interventions

Type	Name	Description
BIOLOGICAL	FluMist	0.5 ml of vaccine intranasally (0.25 ml in each nostril) which contains approximately 107 TCID50 of each type

Timeline

• Start date: 2004-10-01
• Primary completion: 2005-04-01
• Completion: 2005-04-01
• First posted: 2005-09-19
• Last updated: 2008-09-22

Locations

2 sites across 1 country: United States